SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

导出 OA

翻译打印收藏纠错

作者： Desheng,Zhai ^[1] ; Songji,Li ^[2] ; Ying,Zhao ^[3] ; Zhicheng,Lin ^[4]

作者单位： Department of Public Health, Xinxiang Medical University, Xinxiang 453003, China. ^[1] School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China. ^[2] School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China; Department of Psychiatry and Harvard NeuroDiscovery Center, Harvard Medical School and Laboratory of Psychiatric Neurogenomics, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA. Electronic address: zhaoyingxxmc@163.com. ^[3] Department of Psychiatry and Harvard NeuroDiscovery Center, Harvard Medical School and Laboratory of Psychiatric Neurogenomics, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA. Electronic address: zhicheng_lin@hms.harvard.edu. ^[4]

关键词 Dopamine transporter Genetic etiology Neurodegeneration Parkinson's disease Polymorphism

主题词多巴胺质膜转运蛋白质类(Dopamine Plasma Membrane Transport Proteins);女(雌)性(Female);遗传关联研究(Genetic Association Studies);人类(Humans);男(雄)性(Male);帕金森病(Parkinson Disease);危险因素(Risk Factors)

DOI 10.1016/j.neulet.2013.10.060

PMID 24211691

发布时间 2024-03-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交